These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 38799433)

  • 21. Potent STING activation stimulates immunogenic cell death to enhance antitumor immunity in neuroblastoma.
    Wang-Bishop L; Wehbe M; Shae D; James J; Hacker BC; Garland K; Chistov PP; Rafat M; Balko JM; Wilson JT
    J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32169869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor-Targeted Nanomedicine for Immunotherapy.
    Cabral H; Kinoh H; Kataoka K
    Acc Chem Res; 2020 Dec; 53(12):2765-2776. PubMed ID: 33161717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emerging photodynamic nanotherapeutics for inducing immunogenic cell death and potentiating cancer immunotherapy.
    Zhang S; Wang J; Kong Z; Sun X; He Z; Sun B; Luo C; Sun J
    Biomaterials; 2022 Mar; 282():121433. PubMed ID: 35202933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of immunogenic cell death and immune checkpoint blockade therapy.
    Lin RA; Lin JK; Lin SY
    Kaohsiung J Med Sci; 2021 Jun; 37(6):448-458. PubMed ID: 33636043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biomimetic Active Materials Guided Immunogenic Cell Death for Enhanced Cancer Immunotherapy.
    Huang G; Liu L; Pan H; Cai L
    Small Methods; 2023 May; 7(5):e2201412. PubMed ID: 36572642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanoparticle-Mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy.
    Duan X; Chan C; Lin W
    Angew Chem Int Ed Engl; 2019 Jan; 58(3):670-680. PubMed ID: 30016571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequentially pH-Responsive Drug-Delivery Nanosystem for Tumor Immunogenic Cell Death and Cooperating with Immune Checkpoint Blockade for Efficient Cancer Chemoimmunotherapy.
    Jiang M; Chen W; Yu W; Xu Z; Liu X; Jia Q; Guan X; Zhang W
    ACS Appl Mater Interfaces; 2021 Sep; 13(37):43963-43974. PubMed ID: 34506118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetically Edited Cascade Nanozymes for Cancer Immunotherapy.
    Zhang J; Pan Y; Liu L; Xu Y; Zhao C; Liu W; Rao L
    ACS Nano; 2024 May; 18(19):12295-12310. PubMed ID: 38695532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenic cell death in colon cancer prevention and therapy.
    Ruan H; Leibowitz BJ; Zhang L; Yu J
    Mol Carcinog; 2020 Jul; 59(7):783-793. PubMed ID: 32215970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive analysis of the immunogenic cell death-related signature for predicting prognosis and immunotherapy efficiency in patients with lung adenocarcinoma.
    Cui Y; Li Y; Long S; Xu Y; Liu X; Sun Z; Sun Y; Hu J; Li X
    BMC Med Genomics; 2023 Aug; 16(1):184. PubMed ID: 37553698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiviral Responses in Cancer: Boosting Antitumor Immunity Through Activation of Interferon Pathway in the Tumor Microenvironment.
    Vitiello GAF; Ferreira WAS; Cordeiro de Lima VC; Medina TDS
    Front Immunol; 2021; 12():782852. PubMed ID: 34925363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanocarrier-Mediated Immunogenic Cell Death for Melanoma Treatment.
    Wang J; Ma J; Tai Z; Li L; Zhang T; Cheng T; Yu J; Zhu Q; Bao L; Chen Z
    Int J Nanomedicine; 2023; 18():7149-7172. PubMed ID: 38059000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nano-sized drug delivery systems to potentiate the immune checkpoint blockade therapy.
    Shim MK; Song SK; Jeon SI; Hwang KY; Kim K
    Expert Opin Drug Deliv; 2022 Jun; 19(6):641-652. PubMed ID: 35603410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenic cell death in cancer immunotherapy.
    Choi M; Shin J; Lee CE; Chung JY; Kim M; Yan X; Yang WH; Cha JH
    BMB Rep; 2023 May; 56(5):275-286. PubMed ID: 37081756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological inhibitors of anaplastic lymphoma kinase (ALK) induce immunogenic cell death through on-target effects.
    Petrazzuolo A; Perez-Lanzon M; Martins I; Liu P; Kepp O; Minard-Colin V; Maiuri MC; Kroemer G
    Cell Death Dis; 2021 Jul; 12(8):713. PubMed ID: 34272360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenic Cell Death: An Emerging Target in Gastrointestinal Cancers.
    Chiaravalli M; Spring A; Agostini A; Piro G; Carbone C; Tortora G
    Cells; 2022 Sep; 11(19):. PubMed ID: 36230995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-derived nanovesicles enhance cancer synergistic chemo-immunotherapy by promoting cGAS/STING pathway activation and immunogenetic cell death.
    Guo Y; Qian R; Li Z; Lv T; Yang C; Li W; Pan T; Hou X; Wang Z
    Life Sci; 2024 Jul; 348():122687. PubMed ID: 38718856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The intrinsic immunogenic properties of cancer cell lines, immunogenic cell death, and how these influence host antitumor immune responses.
    Aaes TL; Vandenabeele P
    Cell Death Differ; 2021 Mar; 28(3):843-860. PubMed ID: 33214663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A phenolic based tumor-permeated nano-framework for immunogenic cell death induction combined with PD-L1 immune checkpoint blockade.
    Sun X; Zhang J; Xiu J; Zhao X; Yang C; Li D; Li K; Hu H; Qiao M; Chen D; Zhao X
    Biomater Sci; 2022 Jul; 10(14):3808-3822. PubMed ID: 35670432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural Compounds of Marine Origin as Inducers of Immunogenic Cell Death (ICD): Potential Role for Cancer Interception and Therapy.
    Sansone C; Bruno A; Piscitelli C; Baci D; Fontana A; Brunet C; Noonan DM; Albini A
    Cells; 2021 Jan; 10(2):. PubMed ID: 33504012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.